Most cited papers in Multiple and Secondary Primary Cancers
What are the most cited papers in Multiple and Secondary Primary Cancers?
The most cited paper in Multiple and Secondary Primary Cancers is "Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries" (Hyuna Sung, Adalberto M. Filho, Mathieu Laversanne et al., 2021), with 114,522 citations. Next come "Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012" (29,250) and "Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries" (25,936).
Showing 50 of 100 papers. Every paper with more than 961 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries Hyuna Sung, Adalberto M. Filho, Mathieu Laversanne et al. · CA A Cancer Journal for Clinicians | 4 Feb 2021 | 114,522 |
| 2 | Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 Jacques Ferlay, Isabelle Soerjomataram, Rajesh Prabhakar Dikshit et al. · International Journal of Cancer | 13 Sep 2014 | 29,250 |
| 3 | Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries Freddie Bray, Mathieu Laversanne, Hyuna Sung et al. · CA A Cancer Journal for Clinicians | 4 Apr 2024 | 25,936 |
| 4 | Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 Jacques Ferlay, Hai‐Rim Shin, Freddie Bray et al. · International Journal of Cancer | 17 Jun 2010 | 21,446 |
| 5 | Cancer Statistics, 2010 Ahmedin Jemal, Rebecca L. Siegel, Jiaquan Xu et al. · CA A Cancer Journal for Clinicians | 7 Jul 2010 | 12,627 |
| 6 | Cancer Statistics, 2008 Ahmedin Jemal, Rebecca L. Siegel, Elizabeth Ward et al. · CA A Cancer Journal for Clinicians | 28 Jan 2008 | 10,219 |
| 7 | PD-1 Blockade in Tumors with Mismatch-Repair Deficiency Dung Thi Le et al. · New England Journal of Medicine | 30 May 2015 | 9,595 |
| 8 | Cancer Statistics, 2007 Ahmedin Jemal, Rebecca L. Siegel, Elizabeth Ward et al. · CA A Cancer Journal for Clinicians | 2007 | 7,489 |
| 9 | Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015 Christina Fitzmaurice et al. · JAMA Oncology | 5 Dec 2016 | 6,333 |
| 10 | Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries Claudia Allemani et al. · The Lancet | 31 Jan 2018 | 6,323 |
| 11 | Cancer treatment and survivorship statistics, 2016 Kimberly D. Miller, Rebecca L. Siegel, Chun Chieh Lin et al. · CA A Cancer Journal for Clinicians | 2 Jun 2016 | 6,175 |
| 12 | Cancer statistics for the year 2020: An overview Jacques Ferlay, Murielle Colombet, Isabelle Soerjomataram et al. · International Journal of Cancer | 5 Apr 2021 | 5,836 |
| 13 | Cancer Statistics, 2005 Ahmedin Jemal, Thomas S. Murray, Elizabeth Ward et al. · CA A Cancer Journal for Clinicians | 2005 | 5,468 |
| 14 | Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies Andrew G. Renehan, Margaret Tyson, Matthias Egger et al. · The Lancet | Feb 2008 | 5,283 |
| 15 | Triple-Negative Breast Cancer: Clinical Features and Patterns of Recurrence Rebecca Alexandra Dent, Maureen Trudeau, Kathleen I. Pritchard et al. · Clinical Cancer Research | Aug 2007 | 5,223 |
| 16 | Cancer treatment and survivorship statistics, 2019 Kimberly D. Miller, Letícia Nogueira, Angela B. Mariotto et al. · CA A Cancer Journal for Clinicians | 11 Jun 2019 | 4,443 |
| 17 | Estimates of the cancer incidence and mortality in Europe in 2006 Jacques Ferlay, Philippe Autier, Mathieu Boniol et al. · Annals of Oncology | 7 Feb 2007 | 4,051 |
| 18 | Cancer statistics in China and United States, 2022: profiles, trends, and determinants Changfa Xia, Xuesi Dong, He Li et al. · Chinese Medical Journal | 9 Feb 2022 | 3,687 |
| 19 | Radical Cystectomy in the Treatment of Invasive Bladder Cancer: Long-Term Results in 1,054 Patients John P. Stein, Gary Lieskovsky, Rick Cote et al. · Journal of Clinical Oncology | Feb 2001 | 3,563 |
| 20 | Increasing Incidence of Thyroid Cancer in the United States, 1973-2002 Louise Davies, H. Gilbert Welch · JAMA | 9 May 2006 | 3,387 |
| 21 | Colonoscopic Polypectomy and Long-Term Prevention of Colorectal-Cancer Deaths Ann Graham Zauber, Sidney J. Winawer, Michael J. O’Brien et al. · New England Journal of Medicine | 22 Feb 2012 | 3,214 |
| 22 | Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair–Deficient Cancer: Results From the Phase II KEYNOTE-158 Study Aurélien Marabelle et al. · Journal of Clinical Oncology | 4 Nov 2019 | 3,072 |
| 23 | Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020 Wei Cao, Hongda Chen, Yiwen Yu et al. · Chinese Medical Journal | 4 Mar 2021 | 3,051 |
| 24 | Cancer treatment and survivorship statistics, 2014 Carol E. Desantis, Chun Chieh Lin, Angela B. Mariotto et al. · CA A Cancer Journal for Clinicians | Jun 2014 | 2,812 |
| 25 | The Global Burden of Cancer 2013 Christina Fitzmaurice et al. · JAMA Oncology | 28 May 2015 | 2,767 |
| 26 | Global surveillance of cancer survival 1995–2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2) Claudia Allemani et al. · The Lancet | 25 Nov 2014 | 2,690 |
| 27 | Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends Sébastien Antoni, Jacques Ferlay, Isabelle Soerjomataram et al. · European Urology | 29 Jun 2016 | 2,669 |
| 28 | Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer Ernest L. Mazzaferri, Sissy Meihua Jhiang · The American Journal of Medicine | Nov 1994 | 2,662 |
| 29 | Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study Aurélien Marabelle et al. · The Lancet Oncology | 10 Sep 2020 | 2,600 |
| 30 | Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018 Jacques Ferlay, Murielle Colombet, Isabelle Soerjomataram et al. · European Journal of Cancer | 9 Aug 2018 | 2,566 |
| 31 | Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma Thierry O. Philip, Cesare Guglielmi, Anton Hagenbeek et al. · New England Journal of Medicine | 7 Dec 1995 | 2,458 |
| 32 | Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN Eileen Morgan, Melina Arnold, Andrea Gini et al. · Gut | 8 Sep 2022 | 2,412 |
| 33 | Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors Prashanth Rawla, Tagore Sunkara, Adam A. Barsouk · Gastroenterology Review | 2019 | 2,370 |
| 34 | Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer Sarah‐Jane Dawson, Dana W.Y. Tsui, Muhammed Murtaza et al. · New England Journal of Medicine | 13 Mar 2013 | 2,250 |
| 35 | Cancer incidence and mortality in China, 2022 Bingfeng Han, Rongshou Zheng, Hongmei Zeng et al. · Journal of the National Cancer Center | Feb 2024 | 2,238 |
| 36 | Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013 Hyeyeun Lim, Susan S. Devesa, Julie Ann Sosa et al. · JAMA | 31 Mar 2017 | 2,228 |
| 37 | Colorectal Cancer Epidemiology: Incidence, Mortality, Survival, and Risk Factors Fatima A. Haggar, Robin P. Boushey · Clinics in Colon and Rectal Surgery | Nov 2009 | 2,047 |
| 38 | Noninvasive Detection of Clinically Occult Lymph-Node Metastases in Prostate Cancer Mukesh G. Harisinghani, Jelle O. Barentsz, Peter F. Hahn et al. · New England Journal of Medicine | 19 Jun 2003 | 1,987 |
| 39 | An Immunohistochemical Study Peter G. Isaacson, Ahmet Doǧan, Stephen K. Price et al. · The American Journal of Surgical Pathology | Dec 1989 | 1,920 |
| 40 | Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE-5—a population-based study Roberta De Angelis, Milena Sant, Michel P. Coleman et al. · The Lancet Oncology | 5 Dec 2013 | 1,916 |
| 41 | Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer Anna Bill‐Axelson, Lars Holmberg, Mirja L. Ruutu et al. · New England Journal of Medicine | 4 May 2011 | 1,908 |
| 42 | Global estimates of cancer prevalence for 27 sites in the adult population in 2008 Freddie Bray, Jiansong Ren, Eric Masuyer et al. · International Journal of Cancer | 3 Jul 2012 | 1,907 |
| 43 | Survival and Prognostic Stratification of 670 Patients With Advanced Renal Cell Carcinoma Robert John Motzer, Madhu Mazumdar, Jennifer Bacik et al. · Journal of Clinical Oncology | Aug 1999 | 1,812 |
| 44 | Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5·24 million UK adults Krishnan Bhaskaran, Ian Douglas, Harriet J. Forbes et al. · The Lancet | Aug 2014 | 1,742 |
| 45 | Future of Cancer Incidence in the United States: Burdens Upon an Aging, Changing Nation Benjamin D. Smith, Grace L. Smith, Arti Hurria et al. · Journal of Clinical Oncology | 30 Apr 2009 | 1,742 |
| 46 | Nephrectomy Followed by Interferon Alfa-2b Compared with Interferon Alfa-2b Alone for Metastatic Renal-Cell Cancer Robert Charles Flanigan, Sydney E. Salmon, Brent A. Blumenstein et al. · New England Journal of Medicine | 6 Dec 2001 | 1,742 |
| 47 | CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2007-2011 Quinn T. Ostrom, Haley R Gittleman, P. Liao et al. · Neuro-Oncology | Oct 2014 | 1,740 |
| 48 | Hepatocellular Carcinoma Incidence, Mortality, and Survival Trends in the United States From 1975 to 2005 Sean F. Altekruse, Katherine A. McGlynn, Marsha E. Reichman · Journal of Clinical Oncology | 17 Feb 2009 | 1,702 |
| 49 | Epidemiology of Renal Cell Carcinoma Umberto Capitanio, Karim Bensalah, Axel Bex et al. · European Urology | 20 Sep 2018 | 1,699 |
| 50 | Changing cancer survival in China during 2003–15: a pooled analysis of 17 population-based cancer registries Hongmei Zeng et al. · The Lancet Global Health | 10 Apr 2018 | 1,620 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for a field when OpenAlex files it under one of the field's topics; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.